National Peroxide Ltd is Rated Hold

2 hours ago
share
Share Via
National Peroxide Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
National Peroxide Ltd is Rated Hold

Current Rating and Its Significance

MarketsMOJO’s 'Hold' rating for National Peroxide Ltd indicates a neutral stance on the stock, suggesting that investors should maintain their existing positions rather than aggressively buying or selling. This rating reflects a balanced view of the company’s prospects, considering both strengths and challenges in its business and market environment. The Mojo Score, a composite indicator of various performance parameters, currently stands at 54.0, down from 70.0 at the previous rating update, signalling a moderation in the stock’s overall appeal.

Quality Assessment: Average Fundamentals

As of 11 June 2026, National Peroxide Ltd’s quality grade is assessed as average. The company operates in the commodity chemicals sector and is classified as a microcap entity. While it is net-debt free, which is a positive indicator of financial stability, its long-term growth trajectory has been subdued. Over the past five years, net sales have declined at an annualised rate of -6.72%, and operating profit has contracted by -24.68% annually. These figures highlight challenges in sustaining revenue and profitability growth over the medium term.

Valuation: Attractive Pricing

The stock’s valuation is currently attractive, supported by a price-to-book value of 0.9, which suggests it is trading at a discount relative to its book value and peers. The return on equity (ROE) stands at a modest 3.2%, reflecting moderate profitability. Despite the subdued growth, the valuation metrics imply that the market may be pricing in the company’s challenges, offering a potential value opportunity for investors who prioritise price discipline.

Financial Trend: Very Positive Recent Performance

Contrasting with the longer-term growth concerns, the latest financial data as of 11 June 2026 shows a very positive trend in profitability. The company reported a remarkable 333.33% increase in net profit, with profits rising by 616.4% over the past year. The latest six months saw a profit after tax (PAT) of ₹10.34 crores, while quarterly net sales reached a record ₹85.68 crores. Operating profit before depreciation and interest (PBDIT) also hit a high of ₹14.88 crores in the most recent quarter. These results reflect a strong operational turnaround and improved earnings momentum, which partly underpin the current 'Hold' rating.

Technical Analysis: Mildly Bearish Signals

From a technical perspective, the stock exhibits mildly bearish tendencies. Recent price movements show a decline of -0.90% on the day of analysis, with a one-month drop of -20.21%. However, the stock has rebounded over the last three months with a gain of +40.76%, and a year-to-date return of +14.27%. Despite this, the one-year return remains negative at -25.84%, underperforming the broader BSE500 index, which itself declined by -5.03% over the same period. This mixed technical picture suggests caution, as the stock faces resistance in sustaining upward momentum.

Market Position and Shareholding

National Peroxide Ltd is primarily promoter-owned, which often implies stable management control and alignment of interests with shareholders. The company’s microcap status and commodity chemicals sector exposure mean it is sensitive to raw material price fluctuations and cyclical demand patterns, factors that investors should consider when evaluating risk.

Summary for Investors

In summary, the 'Hold' rating reflects a nuanced view of National Peroxide Ltd’s current standing. While the company faces challenges in long-term growth and technical indicators show some bearishness, its attractive valuation and recent strong financial performance provide a counterbalance. Investors should weigh these factors carefully, recognising that the stock may offer value but also carries risks related to market volatility and sector dynamics.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

Performance Metrics in Detail

Examining the stock’s recent returns as of 11 June 2026, the one-day change was -0.90%, reflecting short-term volatility. Over one week, the stock declined by -6.68%, and over one month, it fell by -20.21%. However, the three-month return was robust at +40.76%, indicating a significant recovery phase. The six-month return was +9.06%, and year-to-date gains stood at +14.27%. Despite these positive shorter-term returns, the stock’s one-year performance remains negative at -25.84%, highlighting the uneven nature of its price trajectory.

Financial Strength and Outlook

National Peroxide Ltd’s net-debt-free status is a key strength, reducing financial risk and interest burden. The company’s recent quarterly results demonstrate operational improvements, with the highest quarterly net sales and PBDIT recorded in the latest period. This suggests that management initiatives and market conditions have begun to positively impact the business. However, the negative compound annual growth rates in net sales and operating profit over five years indicate structural challenges that may limit sustained growth without strategic changes.

Valuation Context Compared to Peers

The stock’s price-to-book ratio of 0.9 places it at a discount relative to its peers’ historical valuations, which may attract value-oriented investors. The low PEG ratio of zero further suggests that the stock’s price does not fully reflect its recent profit growth, potentially signalling an undervaluation. Nevertheless, investors should remain cautious given the company’s modest ROE and sector cyclicality.

Investor Considerations

For investors, the 'Hold' rating advises a measured approach. Those currently holding the stock may consider maintaining their positions to benefit from the recent positive earnings momentum, while new investors might wait for clearer signs of sustained growth or technical strength before committing capital. The stock’s microcap status and sector exposure imply higher volatility, so portfolio diversification and risk management remain important.

Conclusion

National Peroxide Ltd’s current 'Hold' rating by MarketsMOJO, last updated on 27 May 2026, reflects a balanced assessment of its average quality, attractive valuation, very positive recent financial trend, and mildly bearish technical outlook. As of 11 June 2026, the stock presents a mixed picture with both opportunities and risks. Investors should carefully analyse these factors in the context of their investment objectives and risk tolerance.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News